Skip to content
OpenCapital
Get started

Wave Life Sciences WVE Common stock, no par value (in dollars per share)

Common stock, no par value (in dollars per share) at other companies

Biohaven logo
BiohavenBHVN
——

Other financials

Income statement

See full
Revenue$38.2M+317%
Operating income-$31.3M+37.2%
Net income-$26.1M+44.4%
EPS (diluted)-$0.13+55.2%

Balance sheet

See full
Cash & equivalents$544.6M+124%
Total debt$15.7M-33.4%
Total equity$511.7M+198%
Total assets$583.5M+102%

Cash flow

See full
Operating cash flow-$59.6M+5.5%
CapEx$438.0K+165%
Free cash flow-$60.0M+5.1%

Valuation

See full
Market cap$1.11B+9.2%
Enterprise value$577.44M-27.2%
P/S14.6×-11.8×

Profitability

See full
Operating margin-75.7%-33.6pp
Net margin-66.5%-29.9pp
FCF margin-27.2%-12.6pp

Returns & leverage

See full
Return on equity-53.7%—
Debt / equity0×-0.1×
Current ratio11.3×+8.3×